APTARGROUP INC

ATR refers to the common stock of AptarGroup, Inc., a company listed on the New York Stock Exchange under the ticker ATR. The stock represents ownership in a global provider of drug delivery, consumer product dispensing, and active material science solutions. ATR shares trade in the U.S. equity market and are followed by investors interested in packaging and healthcare-related businesses.

ATR operates primarily in the packaging and containers industry, with a focus on drug delivery and dispensing systems. The company serves pharmaceutical, beauty, personal care, home care, and food and beverage markets. Its business combines healthcare and consumer packaging segments, which can expose ATR to trends in both medical spending and consumer demand. This dual focus distinguishes it from many traditional packaging companies.

Recent performance for ATR can be found in the latest price data and charts displayed on this page. Short-term moves may reflect quarterly earnings, changes in guidance, or broader market conditions. For precise recent returns, compare the current price with prior closing prices shown in the ATR quote and performance sections.

Valuation analysis for ATR typically involves comparing metrics such as the price-to-earnings ratio, price-to-sales ratio, and enterprise value to EBITDA against peers in packaging and healthcare-related industries. Investors may also review free cash flow yield and dividend-adjusted multiples. These metrics should be considered alongside ATR's growth prospects, profit margins, and balance sheet strength. Current valuation figures are available on the ATR stock page.

Yes, AptarGroup has a history of paying dividends to shareholders. The company has paid regular quarterly dividends, and its dividend policy is determined by the board of directors based on earnings, cash flow, and financial condition. For the latest dividend amount, yield, and payment schedule, please refer to the dividend information displayed on this page.

Key risks for ATR include exposure to fluctuations in raw material costs, particularly resin and other inputs, as well as changes in demand from pharmaceutical and consumer customers. The company also faces currency risk from international operations, regulatory risks, and competition. Additionally, economic downturns or supply chain disruptions could affect ATR's financial performance and stock price.